These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26133157)

  • 1. Atrial fibrillation and hypertrophic cardiomyopathy: who to anticoagulate?
    Frontera A; Wilson DG; Sekhon H; Duncan ER; Thomas G
    Clin Res Cardiol; 2015 Oct; 104(10):799-802. PubMed ID: 26133157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin K antagonist use for all patients with hypertrophic cardiomyopathy and atrial fibrillation: analysis of the literature and guideline review.
    Oliphant CS; McCullough J; Hashim T; Khouzam RN
    Future Cardiol; 2014 Mar; 10(2):229-33. PubMed ID: 24762250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke and Embolic Events in Hypertrophic Cardiomyopathy: Risk Stratification in Patients Without Atrial Fibrillation.
    Haruki S; Minami Y; Hagiwara N
    Stroke; 2016 Apr; 47(4):936-42. PubMed ID: 26941260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic cardiomyopathy: a real risk factor for stroke.
    Badawi RA; Seetharaman S; Birns J
    Scott Med J; 2012 Feb; 57(1):60. PubMed ID: 22194403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation for stroke prevention in patients with hypertrophic cardiomyopathy and atrial fibrillation: A review.
    Nasser MF; Gandhi S; Siegel RJ; Rader F
    Heart Rhythm; 2021 Feb; 18(2):297-302. PubMed ID: 33022393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Link MS; Maron MS; Maron BJ
    Circulation; 2023 Nov; 148(22):1797-1811. PubMed ID: 38011245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
    Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation in hypertrophic cardiomyopathy: mechanisms, embolic risk and prognosis.
    Nair AG; Fischer AG
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():40-3. PubMed ID: 17162269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation.
    Dominguez F; Climent V; Zorio E; Ripoll-Vera T; Salazar-Mendiguchía J; García-Pinilla JM; Urbano-Moral JA; Fernández-Fernández X; Lopez-Cuenca D; Ajo-Ferrer R; Sanz-Sanchez J; Gomez-Perez Y; López-Garrido MA; Barriales-Villa R; Gimeno JR; Garcia-Pavia P
    Int J Cardiol; 2017 Dec; 248():232-238. PubMed ID: 28811092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous left atrial appendage closure in patients with hypertrophic cardiomyopathy and persistent atrial fibrillation: 3-year-followed case series.
    Liu Y; Chen C; Chen Y; Su X; Li Z; Chen Y
    Medicine (Baltimore); 2023 Apr; 102(17):e33646. PubMed ID: 37115077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic difference between paroxysmal and non-paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Yashiro B; Minami Y; Terajima Y; Hagiwara N
    J Cardiol; 2014 Jun; 63(6):432-7. PubMed ID: 24280311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Kubo T; Baba Y; Ochi Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
    ESC Heart Fail; 2021 Dec; 8(6):5022-5030. PubMed ID: 34472710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management.
    Garg L; Gupta M; Sabzwari SRA; Agrawal S; Agarwal M; Nazir T; Gordon J; Bozorgnia B; Martinez MW
    Heart Fail Rev; 2019 Mar; 24(2):189-197. PubMed ID: 30456592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dofetilide for suppression of atrial fibrillation in hypertrophic cardiomyopathy: A case series and literature review.
    Moore JC; Trager L; Anzia LE; Saliba W; Bassiouny M; Bhargava M; Chung M; Desai M; Garberich R; Lever H; Lindsay BD; Sengupta J; Tchou P; Wazni O; Wilkoff BL
    Pacing Clin Electrophysiol; 2018 Apr; 41(4):396-401. PubMed ID: 29450893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality.
    Zegkos T; Efthimiadis GK; Parcharidou DG; Gossios TD; Giannakoulas G; Ntelios D; Ziakas A; Paraskevaidis S; Karvounis HI
    Hellenic J Cardiol; 2017; 58(5):331-339. PubMed ID: 28219794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression.
    Di Donna P; Olivotto I; Delcrè SD; Caponi D; Scaglione M; Nault I; Montefusco A; Girolami F; Cecchi F; Haissaguerre M; Gaita F
    Europace; 2010 Mar; 12(3):347-55. PubMed ID: 20173211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the incidence of atrial fibrillation and stroke in hypertrophic cardiomyopathy patients: insights from Danish nationwide registries.
    Zörner CR; Schjerning AM; Jensen MK; Christensen AH; Tfelt-Hansen J; Tønnesen J; Riis-Vestergaard LD; Middelfart C; Rasmussen PV; Gislason G; Hansen ML
    Europace; 2024 Jul; 26(7):. PubMed ID: 38917047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review.
    Alphonse P; Virk S; Collins J; Campbell T; Thomas SP; Semsarian C; Kumar S
    Clin Res Cardiol; 2021 Apr; 110(4):544-554. PubMed ID: 32880676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Profile of Thromboembolic Events in Patients With Hypertrophic Cardiomyopathy in a Regional Japanese Cohort　- Results From Kochi RYOMA Study.
    Hirota T; Kubo T; Baba Y; Ochi Y; Takahashi A; Yamasaki N; Hamashige N; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
    Circ J; 2019 Jul; 83(8):1747-1754. PubMed ID: 31257313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.